Catalyst Pharmaceuticals, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCoral Gables, FL
US patents2
SAM.gov UEIJ1B2ARLKWN53
CAGE code5UTL7
Incorporated inDE
LEI5299004O0R5XXLA5H544
- difficult-to-treat conditions
- marketed therapies
- patient communities
- LEMS
- disease education
- financial support
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted 2015–2016, none of them in the five years to SEP 2025.
Pharmaceuticals 2
- Method of treating Tourette'S disorder with GABA-aminotransferase inactivatorsUS 9,254,274 · granted FEB 9, 2016
- Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acidUS 8,969,413 · granted MAR 3, 2015
Granted to Catalyst Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Catalyst Pharmaceuticals, INC | Coral Gables | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.